Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EBIT Growth(%) 3.62-40.091,061.31222.71-153.82

What is the latest EBIT Growth ratio of VENUS REMEDIES ?

The latest EBIT Growth ratio of VENUS REMEDIES is 3.62 based on Mar2023 Consolidated results.
Year EBIT Growth
Mar20233.62
Mar2022-40.09
Mar20211,061.31
Mar2020222.71
Mar2019-153.82

How is EBIT Growth of VENUS REMEDIES Trending?

Years EBIT Growth % Change
Mar2023 3.62
Positive
Mar2022 -40.09
Negative
Mar2021 1061.31
376.54
Mar2020 222.71
Positive
Mar2019 -153.82 -

Other Financial Ratios of VENUS REMEDIES


Compare EBIT Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹396.1 Cr -4.6% -13.8% 49.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹366,103.0 Cr 0.7% -4.8% 57.3% Stock Analytics
CIPLA ₹114,230.0 Cr 1.9% -2.4% 42.6% Stock Analytics
DIVIS LABORATORIES ₹103,916.0 Cr 0.1% 3% 12.1% Stock Analytics
ZYDUS LIFESCIENCES ₹99,939.2 Cr 1.3% 0.5% 87.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,732.2 Cr -5.4% -4.1% 20% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-4.6%

-13.8%

49.4%

SENSEX

-1.5%

-2.6%

17.8%


You may also like the below Video Courses